Endocare acquires Timm Medical
Executive Summary
Endocare (temperature- and stent-based treatments for cancer and urology) has agreed to acquire Timm Medical Technologies (distributes urological products and devices) for $11mm in cash and 1.62mm Endocare common stock valued at almost $23mm.
Deal Industry
- Distributors
- Medical Devices
-
Medical Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
-
Surgical Equipment & Devices
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Includes Contract
- Payment Includes Cash for Equity
- Payment Includes Stock
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice